Madrigal Pharmaceuticals (MDGL) Revenue (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Revenue of $311.3 million for Q1 2026, up 126.84% year-over-year from $137.2 million in Q1 2025, and down 3.04% quarter-over-quarter from $321.1 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Revenue (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 6 years of Revenue data on file, last reported at $311.3 million in Q1 2026.
- Revenue for Q1 2026 came in at $311.3 million, up 126.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 256.82% YoY), and the FY2025 annual result was $958.4 million, up 432.05% from the prior year.
- Revenue fell to $311.3 million in Q1 2026 per MDGL's latest filing, from $321.1 million in the prior quarter.
- Over five years, Revenue peaked at $321.1 million in Q4 2025 and troughed at $14.6 million in Q2 2024.
- A 3-year average of $181.2 million and a median of $175.0 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2025 and 2026: Revenue jumped 1353.76% in 2025, then soared 126.84% in 2026.
- A 3-year view of Revenue shows it stood at $103.3 million in 2024, then jumped by 210.77% to $321.1 million in 2025, then declined by 3.04% to $311.3 million in 2026.
- Business Quant data shows MDGL's Revenue at $311.3 million in Q1 2026, $321.1 million in Q4 2025, and $287.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | 311.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 311.34 Mn |
| Dec 31, 2025 | 321.08 Mn |
| Sep 30, 2025 | 287.27 Mn |
| Jun 30, 2025 | 212.80 Mn |
| Mar 31, 2025 | 137.25 Mn |
| Dec 31, 2024 | 103.32 Mn |
| Sep 30, 2024 | 62.18 Mn |
| Jun 30, 2024 | 14.64 Mn |
| Mar 31, 2012 | 147,000.00 |
| Dec 31, 2011 | 3.42 Mn |
| Sep 30, 2011 | 521,000.00 |
| Jun 30, 2011 | 211,000.00 |
| Mar 31, 2011 | 1.14 Mn |
| Dec 31, 2010 | 4.04 Mn |
| Sep 30, 2010 | 3.38 Mn |
| Jun 30, 2010 | 3.36 Mn |